LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Synergistic antinociception between ZC88, an N‐type voltage‐dependent calcium channel blocker, and ibuprofen in mouse models of visceral and somatic inflammatory pain

Photo by stayandroam from unsplash

A combination of analgesic agents with different mechanisms can induce additive or synergistic analgesia. The N‐type voltage‐dependent calcium channel (N‐VDCC) is a novel therapeutic target for pain control. In addition… Click to show full abstract

A combination of analgesic agents with different mechanisms can induce additive or synergistic analgesia. The N‐type voltage‐dependent calcium channel (N‐VDCC) is a novel therapeutic target for pain control. In addition to providing effective pain relief when used alone, N‐VDCC blockers produce synergistic analgesia when used in combination with opiates. However, the interaction between N‐VDCC blockers and nonsteroidal anti‐inflammatory drugs (NSAIDs) remains unclear.

Keywords: type voltage; calcium channel; dependent calcium; voltage dependent; pain

Journal Title: European Journal of Pain
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.